Sign Up for Updates
* Required fields
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.
At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.
Intuitive
Safe
Convenient
Seamless
0%
of the top 50 US heart hospitals have adopted HeartFlow
0%
US commercial lives covered
Strength in numbers
Highest Performance
- 2x more likely to identify
disease than other tests1 - 40% reduction in layered,
repeat testing2 - 83% of unnecessary coronary angiograms cancelled3
Proven Outcomes
- Long-term studies with
data out to 5 years - 500+ Peer-Reviewed
Publications - 170,000+ trial and
real-world patients
Highest Performance
Proven Outcomes
- 2x more likely to identify
disease than other tests1 - 40% reduction in layered,
repeat testing2 - 83% of unnecessary coronary angiograms cancelled3
HeartFlow will transform
the way we practice cardiology.
the way we practice cardiology.
Kavitha Chinnaiyan, M.D.,
Dir. of Cardiac Imaging Research,
William Beaumont Hospital
Contact Us
* Required fields
REFERENCES
-
Nørgaard, et al. Euro J Radiol 2015. Incl. Jung, et al. Euro Heart J 2008.
Melikian, et al. JACC Cardiovasc Interv 2010. Koo, et al. JACC 2011.
Min, et al. J Am Med Assoc 2012. Nørgaard, et al. JACC 2014.
Danad, et al. JAMA Cardiol 2017. Driessen, et al. JACC 2019. - Curzen, et al. FORECAST trial presented at TCT Connect 2020.
- Douglas, et al. J Am Coll Cardiol 2016
106759341 v2